Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis

Modern Rheumatology

Volumn 24, Issue 6, 2014, Pages 926-930

  Nakajima, Arata ^a   Aoki, Yasuchika ^a   Shibata, Yoshifumi ^a   Sonobe, Masato ^a   Terajima, Fumiaki ^a   Takahashi, Hiroshi ^a   Saito, Masahiko ^a   Taniguchi, Shinji ^a   Yamada, Manabu ^a   Nakagawa, Koichi ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Disease activity; Oxidative stress; Reactive oxygen metabolites; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; C REACTIVE PROTEIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; REACTIVE OXYGEN METABOLITE; RHEUMATOID FACTOR; STROMELYSIN; TOCILIZUMAB; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIMPLIFIED DISEASE ACTIVITY INDEX; ARTHRITIS, RHEUMATOID; BLOOD; MIDDLE AGED; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84932155377     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2014.891495     Document Type: Article

References (30)

1. Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2009;2(5):361-7.
2. Mapp PI, Grootveld MC. Blake DR. Hypoxia, oxidative stress, and rheumatoid arthritis. Br Med Bull. 1995;51(2):419-36.
3. Hitchon CA, El-Gabalawy H. Oxidation in rheumatoid arthritis. Arthritis Res Ther. 2004;6:265-78.
4. Halliwell B, Oxygen radicals, nitric oxide, and human inflammatory joint disease. Ann Rheum Dis. 1995;54(6):505-10.
5. Tak PP, Zvaifler NJ, Grenn DR, Firestein GS. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today. 2000;21(2):78-82.
6. Biemond P, Swaak AJ, Koster JF. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthritis Rheum. 1984;27(7):760-5.
7. Griffiths HR, ROS as signaling molecules in T cells - evidence for abnormal redox signaling in the autoimmune disease, rheumatoid arthritis. Redox Rep. 2005;10(6):273-80.
8. Carratelli M, Porcaro L, Ruscica M, De Simone E. Bertelli AA, Corsi MM. Reactive oxygen metabolites and prooxidant status in children with Down’s syndrome. Int J Clin Pharm Res. 2001;21(2):79-84.
9. Trotti R, Carratelli M, Barbieri M, Micieli G, Bosone D. Rondanelli M, Bo P. Oxidative stress and a thrombophilic condition in alcoholics without severe liver disease. Haematologica. 2001:86(1):85-91.
10. Faienza MF, Francavilla R, Goffredo R, Ventura A, Marzano F, Panzarino G, et al. Oxidative stress in obesity and metabolic syndrome in children and adolescents. Horm Res Paediatr. 2012;78(3): 158-64.
11. Coaccioli S, Standoli ML, Biondi R, Panaccione A, Landucci P. Del Giorno R, et al. Assessment of the oxidative stress markers in patients with chronic renal insufficiency undergoing dialysis treatment. Clin Ter. 2010;161(5):441-4.
12. Koutsokera A, Papaioannou Al, Malli F, Kiropoulos TS, Katsabeki A, Kerenidi T, et al. Systemic oxidative stress in patients with pulmonary sarcoidosis. Pulm Pharmacol Ther. 2009;22(6):603-7.
13. Suzuki S, Matsukura S, Takeuchi H, Kawaguchi M, Ieki K, Odaka M, et al. Increase in reactive oxygen metabolite level in acute exacerbations of asthma. Int Arch Allergy Immunol. 2008; 146 Suppl 1:67-72.
14. Kotani K, Koibuchi H, Miyamoto M, Yamada T, Taniguchi N. Relationship between reactive oxygen metabolites and carotid intima- media thickness in subjects with hypercholesterolemia. Med Princ Pract. 2010;19(6):496-8.
15. Yamanaka G, Kawashima H, Suganami Y, Watanabe C, Watanabe Y, Miyajima T. et al. Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy. J Neurol Sci. 2006;243(l-2):71-5.
16. Hirao M, Yamasaki N, Oze H. Ebina K, Nampei A, Kawato Y, et al. Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab. Rheumatol Int. 2011:32(12):4041-5.
17. Yang H, Jin X, Kei Lam CW. Yan SK. Oxidative stress and diabetes mellitus. Clin Chem Lab Med. 2011;49:1773-82.
18. Amaral S, Oliveria PJ, Ramalho-Santos J. Diabetes and impairment of reproductive function: possible role of mitochondria and reactive oxygen species. Curr Diabetes Rev. 2008;4(l):46-54.
19. Hassan SZ, Gheita TA. Kenawy SA, Fahim AT, El-Sorougy IM. Abdou MS. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis. 2011:14(4):325-31.
20. Kundu S, Ghosh P, Datta S. Ghosh A, Chattopadhyay S, Chatterjee M. Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis. Free Radic Res. 2012;46(12): 1482-9.
21. Del Rincon I, Williams K, Stern MP. Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44(12):2737-45.
22. Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 2002;46(4):862-73.
23. Jacobsson LT, Turesson C, Hanson RL, Pillemer S, Sievers ML. Pettitt DJ, et al. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum. 2001;44(5): 1170-6.
24. Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K. Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid, intima-media thickness, and pulse wave velocity. Atherosclerosis. 2004; 173(1): 13-8.
25. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr.. Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340(1): 14-22.
26. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P. Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39(l):10-5.
27. Del Porto F, Lagana B. Lai S, Nofroni I, Tinti F, Vitale M, et al. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology. 2007;46(7):1111-5.
28. Hayashi H, Satoi K, Sato-Mito N, Kaburagi T, Yoshino H. Higaki M, et al. Nutritional status in relation to adipokines and oxidative stress is associated with disease activity in patients with rheumatoid arthritis. Nutrition. 2012;28(11-12):1109-14.
29. Funahashi K, Koyano S, Miura T, Hagiwara T, Okuda K. Matsubara T. Efficacy of tocilizumab and evaluation of clinical remission as determined by CDAI and MMP-3 level. Mod Rheumatol. 2009;19(5):507-12.
30. Ribbens C, Martiny Porras M, Franchimont N, Kaiser MJ, Jaspar JM, Damas P, et al. Increased metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis. 2002;61(2): 161-6.